Dolomite Microfluidics’ Mitos P-Pumps enable reliable production of highly monodisperse droplets
17 May 2017 | By Dolomite Microfluidics
Dolomite Microfluidics’ Mitos P-Pumps are proving popular with customers around the globe....
List view / Grid view
News
EC opens formal investigation into Aspen Pharma’s cancer drug price hikes
17 May 2017 | By Niamh Marriott, Junior Editor
The EC has opened a formal investigation into concerns that Aspen Pharma has engaged in excessive pricing concerning five life-saving cancer medicines...
Sangamo and Pfizer to collaborate on Haemophilia A gene therapy
17 May 2017 | By Niamh Marriott, Junior Editor
Sangamo and Pfizer have announced a global collaboration and license agreement for the development of gene therapy programs for Haemophilia A...
Can crab shells provide a green solution to malaria?
17 May 2017 | By Niamh Marriott, Junior Editor
Study shows how a mixture of chitin and silver nanoparticles inhibits growth of mosquito larvae...
First-in-class innovation a key strategy for harsh pharma market environment
16 May 2017 | By Dominic Trewartha, Managing Analyst for GBI Research
First-in-class innovation is a key strategy that companies have been employing to achieve these imperatives. Over recent decades, in addition to an...
Lessons from Ebola: How to improve disease outbreak management
16 May 2017 | By Niamh Marriott, Junior Editor
A new approach to information gathering could allow scientists to quickly identify the most effective way to manage a disease outbreak...
Thermo Fisher to acquire Patheon in $7.2bn deal
Thermo Fisher Scientific announced yesterday that it would buy contract development and manufacturing organisation (CDMO) Patheon for $7.2bn...
Relocating the EMA: An open letter from EFPIA and Pharma Heads of Research
16 May 2017 | By European Federation of Pharmaceutical Industries and Associations (EFPIA)
The EMA is a world class regulator, whose scientific recommendations are a vital element of the ongoing effort to provide EU citizens with quality medicines
A path toward ending AIDS epidemic in the US by 2025
15 May 2017 | By Niamh Marriott, Junior Editor
A new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the US...
Market pressures and inadequate production restrict access to antibiotics
15 May 2017 | By Niamh Marriott, Junior Editor
Antibiotics are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market...
Antalis Packaging warns of quality control amid corrugated price hikes
15 May 2017 | By Niamh Marriott, Junior Editor
Antalis Packaging says that it is now more important than ever for companies to be watchful on their corrugated box specification and quality...
Quantum dots to shine bright with ROMIL solvents
12 May 2017 | By ROMIL
ROMIL solvents are helping researchers at the Cavendish Laboratory, the University of Cambridge’s Department of Physics, to develop novel quantum dots which could be used in the next generation of solar panels...
SpeeDx and Thermo Fisher Scientific announce strategic partnership for FDA clearance of molecular diagnostic test
ResistancePlus™ MG Test would bring disease and antibiotic resistance testing for potential “superbug”...
The continuum of HIV care: What does it mean and how is Europe doing?
12 May 2017 | By Niamh Marriott, Junior Editor
From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of HIV Care in Europe...
Alzheimer’s experts call for changes in FDA drug approval standards
12 May 2017 | By Niamh Marriott, Junior Editor
Leading Alzheimer's disease researchers published an analysis urging the FDA to clarify and modernise its approach for approval of Alzheimer's drugs...
